Searched for
INSTITUTE FOR IMMUNOLOGY
Stock picks of the week: 6 stocks with consistent score improvement and upside potential of up to 29%At a time when there are so many headwinds for the markets, it is tough to imagine that things can get better. But sentiment is a fickle th...- Serum Institute of India to manufacture Oxford Ebola vaccine backed by $8.6 million CEPI fundingSerum Institute of India will produce clinical trial doses of a new Ebola vaccine from Oxford University. This initiative is backed by fres...
- Scientists trace human blood cells back to ancient single-celled ancestorsScientists have uncovered evidence that human blood and immune cells may have evolved from ancient single-celled organisms nearly 700 milli...
- Ebola vaccine update: Russia claims a breakthrough; Oxford researchers, Serum Institute of India aim to begin trial in 3 monthsA new Ebola vaccine developed by Russian scientists shows promise against the current outbreak strain in the Democratic Republic of Congo. ...
- Time to take measured and logical risks? 5 small-caps from different sectors with upside potential of up to 26%Given the fluctuating situation in the Gulf region because of the US-Iran conflict, there is no guarantee that the market will not fall fur...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 33%, according to analystsThis is easy to say, but difficult to actually implement: As an investor, make a distinction between the day-to-day movement of indices and...
- For risk-takers with long-term perspective: 10 small-cap stocks from different sectors with upside potential of up to 31%If you buy small-cap stocks today, are you taking a risk or managing it? To some it might appear you are taking a risk, but there is a high...
- These large- mid- and small-cap stocks have an upside potential of up to 31% in 1 year, according to analystsAs nothing can be ruled out on the street, be prepared for anything. Now, what is the probability that the bears will be chased away from t...
- Overhaul of drug regulator begins with recruitment plan for 1,500 specialistsIndia's pharmaceutical landscape is on the verge of transformation! The country’s drug regulatory body is gearing up for an overhaul with t...
- Claire Mazumdar: A silent force behind a $1.6 billion firm may write Biocon's future scriptsBiocon founder Kiran Mazumdar-Shaw has named her niece, Claire Mazumdar, as her successor. Claire Mazumdar, a successful CEO of Bicara Ther...
- ACC clears Dr Rajeev Singh Raghuvanshi’s reappointment as Drugs Controller (India)Dr Rajeev Singh Raghuvanshi will continue as Drugs Controller (India) at CDSCO. His reappointment is on a contract basis for one year start...
- Dr Subhash Babu, first Indian scientist to be awarded Bailey K. Ashford MedalThe American Society of Tropical Medicine and Hygiene (ASTMH) is the world's largest scientific organization in tropical medicine, and the ...
- Covaxin has cellular immune memory to Covid for at least 6 months: National Institute of ImmunologyNII has also provided services for COVID-19 research. Under this programme, 65 Medical laboratory technologists (MLTs)/lab technicians were...
- Common cold virus saved lives in IndiaOne of the biggest mysteries of the Covid-19 infection in India relative to other countries like the US and UK has been the lower mortality...
- Coronavirus mutating much faster than before, finds Indian Institute of Science studyTheir recent study, published in the Journal of Proteome Research, has identified multiple mutations and unique proteins in isolates of SAR...
- 'Next-gen' COVID-19 vaccines may be needed to tackle emerging variants, say scientistsWork on vaccines will have to continue on parallel tracks - one to tackle the SARS-CoV-2 virus with first generation vaccines and the other...
- Protein-based COVID-19 vaccine candidates would be more suitable for India, scientists sayThe decision on procuring the right COVID-19 vaccine depends on multiple factors, including safety, price and ease of deployment, the scien...
- Presence of antibodies may not guarantee protection from COVID-19, say scientistsAs worries over India's COVID-19 spike mount - the country added 90,062 cases on Monday to take its tally past the 42-lakh mark - scientist...
- COVID-19: 16 companies get funds for R&D workThe department of biotechnology has granted funds to 16 companies for developing drugs, vaccines and devices to fight the Covid-19 pandemic...
- HLL Biotech enters agreement Croatian instituteHLL Biotech has entered into a long-term supply and technology licence agreement with the Institute of Immunology, Zagreb, Croatia.
Load More
